Suzhou Fushilai Pharmaceutical Co Ltd Sustainability Reports
The company researches, develops, produces, and sells pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and health care raw materials. Its key products include alpha lipoic acid, L-carnosine, and phosphatidylcholine variants used globally in medicines and dietary supplements.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG00CF6BLM0
4 reports from 2023 to 2025